Iron deficiency and resulting anaemia cause fatal comorbidities worldwide. Despite this, they are generally underestimated. Professor Lothar Thomas, specialist in laboratory medicine at Central Laboratory of the University Hospital of Frankfurt/Main, is calling for more information about the new laboratory parameters for diagnosis and monitoring of iron deficiency and iron substitution therapy.
We are seeing great priority shifts in China’s funding for R&D and manufacturing expansion. Even the agency responsible for selecting the recipients has changed, Jie Ren reports from the Beijing-based market analysis consultancy Whitney Research Inc. Report: John Brosky
Gideon Ho, CEO and co-founder of Singapore-based HistoIndex is confident: ‘After a biopsy a patient waits in a hospital bed, but now, instead of waiting a couple days until doctors know how to treat this patient, we can deliver results while the patient is still in the hospital.’ Report: John Brosky
Early diagnosis and effective therapy of periprosthetic joint infections (PJI) remain a challenge for many physicians due to the complexity and heterogeneity of clinical symptoms. As individual solutions are needed, opportunities to discuss and exchange ideas are welcome, as clearly shown during the satellite symposium on the diagnosis and treatment of periprosthetic knee infections held at this…
A new extracorporeal nanotech device addresses the root cause of sepsis by removing pathogens and endotoxins simultaneously from blood even before their identification – this genetically engineered mannose-binding lectin protein can also latch on to the Ebola virus... Report: Cynthia E Keen
It sounds amazingly simple: a structured medical Seldinger guidewire is inserted via a peripheral venous catheter to ‘fish’ for circulating tumour cells (CTC) in the blood of cancer patients. Report: Bettina Döbereiner
Founder, CEO and Chief Scientist of CNOGA Medical Ltd., Dr. Segman will be attending the MEDICA 2015 and available at the company‘s booth to explain the company’s revolutionary healthcare ecosystem vision and business strategy.
In the year of its 40th anniversary, Schiller proudly presents an algorithm which immediately and accurately localises coronary occlusions and provides early detection of STEMI. This algorithm is now integrated in the sophisticated touch ECG devices, the Cardovit MS line.
Infection, the tightest space and fast scanning are the three biggest things clinicians must tackle today in a point of care (POC) environment.
Accident and Emergency (A&E) teams play a key role in identifying patients with sepsis, followed by risk stratification for severe sepsis and septic shock, initiating resuscitation and treatment, and ensuring the correct onward management of patients identified with sepsis. Report: Mark Nicholls
Professor Tobias Welte MD, President of the 24th International Congress of the European Respiratory Society, gave EH some personal views on the symposium ‘New perspectives in the management of nosocomial pneumonia’. Interview: Ralf Mateblowski
In September 2015, Utrecht University and University Medical Center (UMC) Utrecht will begin offering a two-year Biofabrication research master’s program in partnership with three foreign universities.
Donor transplant rejection and cancer relapse have two things in common: early recognition is vital and monitoring is hugely challenged.
Doctor Véronique Mondain from Nice explains the ambitious project she and colleagues have put in place to help combat the rise of these resistant pathogens.
Personalised medicine is often equated with the development of drugs tailored to the genetic make-up of patients or cancers.
Founded in Germany 25 years ago, EKF Diagnostics’ PLC HQ is currently in Cardiff, Wales, where the firm is pursuing the development of a molecular assay for specific cancer types.
The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the highest level of patient care and clinical research.
We live in a connected world, a very different world than it was a decade ago, said Eric Topol MD. Mobile devices, wearable devices are driving a creative revolution, reducing costs of healthcare, increasing patient access to health information.
Viktor Mayer-Schönberger is a visionary author of the book Big Data, which, as its subtitle suggests, defines the debate over the ‘Revolution That Will Transform How We Live, Work, and Think.’
‘Never-before-seen breakthroughs in diagnostic research and technology’ were revealed during July’s American Association for Clinical Chemistry meeting in Chicago, where up to 20,000 people packed in for research updates.
French authorities have given the green light for continuing the clinical trial for the first fully implantable mechanical heart after a four-month review of the device and the causes of death of the first patient to receive the prosthesis
Sepsis kills around a hundred and thirty patients daily In Germany alone. This systemic disease is mostly caused by bacterial pathogens, and less frequently by fungal organisms or parasites. The delayed diagnoses result in high mortality. Professor Dr Frank M Brunkhorst of the Centre of Sepsis Control and Care (CSCC), at Jena University Hospital, Germany, is seeking strategies to combat such…
Treat a proficiency testing (PT) sample just like a patient sample. But don't. That has been the message labs have struggled with and in some cases lost their CLIA certificates over.
Health analysts have predicted that DNA sequencing will shift from a laboratory-based setup to point of care testing within the next five years.
New molecular technologies to screen drug-resistant TB are replacing, for example, culture-based tests that are slow, require experienced personnel, and need stringent microbiological safety precautions.